IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

IM Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026

$1.50+0.11 (+7.91%)

Close on Oct 19, 2026

IM Cannabis Corp. revenue by segment

IM Cannabis does not break out revenue by segment, region or product in the tagged data of its filings for this period type.